These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 11042936)
1. Diabetic eye disease: how can it be prevented? Broadbent DM Practitioner; 2000 Aug; 244(1613):696-700, 702. PubMed ID: 11042936 [No Abstract] [Full Text] [Related]
2. Improving microvascular outcomes in patients with diabetes through management of hypertension. McGill JB Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966 [TBL] [Abstract][Full Text] [Related]
3. [Medical treatment in diabetic retinopathy]. Brănişteanu D; Graur M Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):230-5. PubMed ID: 16607776 [TBL] [Abstract][Full Text] [Related]
4. [Some light on the early phases of diabetic retinopathy]. Hellstedt T; Ikonen P; Weman S; Summanen P Duodecim; 1998; 114(3):295-302. PubMed ID: 10895505 [No Abstract] [Full Text] [Related]
5. [Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective]. Dorhout Mees EJ Ned Tijdschr Geneeskd; 2003 Mar; 147(11):521-2; author reply 522. PubMed ID: 12677953 [No Abstract] [Full Text] [Related]
6. Angiotensin II, VEGF, and diabetic retinopathy. Williams B Lancet; 1998 Mar; 351(9105):837-8. PubMed ID: 9519992 [No Abstract] [Full Text] [Related]
7. [Risk factors of diabetic retinopathy and their control]. Kishikawa H; Araki E; Sakakida M; Nishikawa T; Wake N Nihon Rinsho; 2005 Jun; 63 Suppl 6():237-43. PubMed ID: 15999713 [No Abstract] [Full Text] [Related]
8. [Which antihypertensive therapy is indicated in type 2 diabetic patients?]. Hauner H Dtsch Med Wochenschr; 2002 Jul; 127(28-29):1543-4. PubMed ID: 12111665 [No Abstract] [Full Text] [Related]
9. [Ramipril and new therapeutic possibilities for ACE-inhibitors]. Vespasiani Gentilucci U; Picardi A Clin Ter; 2000; 151(4):307-8. PubMed ID: 11107682 [No Abstract] [Full Text] [Related]
11. Prospects for angiotensin receptor blockers in diabetic retinopathy. Sjølie AK Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive persistence and drug class. Marentette MA; Gerth WC; Billings DK; Zarnke KB Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422 [TBL] [Abstract][Full Text] [Related]
13. [Development of various forms of hypertension and a new assessment of antihypertensive medication]. Middeke M Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1449-51. PubMed ID: 16794973 [No Abstract] [Full Text] [Related]
14. A comprehensive review of antihypertensive agents providing renal protection. Kalus JS; White CM Conn Med; 2001 Oct; 65(10):587-91. PubMed ID: 11702517 [No Abstract] [Full Text] [Related]
15. Hypertension medications and dental considerations. Wynn RL Gen Dent; 2000; 48(2):126-31. PubMed ID: 11199569 [No Abstract] [Full Text] [Related]
16. Primary prevention using losartan in type 1 diabetic patients significantly reduces retinopathy. Cardiovasc J Afr; 2009; 20(4):265. PubMed ID: 19701543 [No Abstract] [Full Text] [Related]
17. [Risk factors to be considered at the beginning of antihypertensive therapy in diabetes mellitus]. Jermendy G Orv Hetil; 2004 May; 145(18):949-56. PubMed ID: 15188641 [TBL] [Abstract][Full Text] [Related]